Nonalcoholic fatty liver disease (NAFLD) severity is associated to a nonhemostatic contribution and proinflammatory phenotype of platelets

Endotoxin Producers Overgrowing in Human Gut Microbiota as the Causative Agents for Nonalcoholic Fatty Liver Disease

(2020) Na Fei et al.   mBio

Platelet GPIbα is a mediator and potential interventional target for NASH and subsequent liver cancer

(2019) Mohsen Malehmir et al.   NATURE MEDICINE

From NASH to HCC: current concepts and future challenges

(2019) Quentin M. Anstee et al.   Nature Reviews Gastroenterology & Hepatology

Epidemiology of chronic liver diseases in the USA in the past three decades

(2019) Zobair M Younossi et al.   GUT

The Global Epidemiology of NAFLD and NASH in Patients with type 2 diabetes: A Systematic Review and Meta-analysis

(2019) Zobair M. Younossi et al.   JOURNAL OF HEPATOLOGY

NAFLD in children: new genes, new diagnostic modalities and new drugs

(2019) Valerio Nobili et al.   Nature Reviews Gastroenterology & Hepatology

Intestinal permeability in the pathogenesis of liver damage: From non-alcoholic fatty liver disease to liver transplantation

(2019) Alberto Nicoletti et al.   WORLD JOURNAL OF GASTROENTEROLOGY

Neutrophils and neutrophil extracellular traps in the liver and gastrointestinal system

(2018) Masaki Honda et al.   Nature Reviews Gastroenterology & Hepatology

Triggering and resolution of inflammation in NASH

(2018) Susanne Schuster et al.   Nature Reviews Gastroenterology & Hepatology

Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease

(2017) Chris Estes et al.   HEPATOLOGY

Low-grade endotoxemia, gut permeability and platelet activation in patients with impaired fasting glucose

(2017) R. Carnevale et al.   NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES

Platelets: No longer bystanders in liver disease

(2016) Abhishek Chauhan et al.   HEPATOLOGY

Low-grade endotoxemia and platelet activation in cirrhosis

(2016) Valeria Raparelli et al.   HEPATOLOGY

The severity of nonalcoholic fatty liver disease is associated with gut dysbiosis and shift in the metabolic function of the gut microbiota

(2016) Jérôme Boursier et al.   HEPATOLOGY

EASL–EASD–EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease

(2016)   JOURNAL OF HEPATOLOGY

Non-alcoholic fatty liver disease and risk of incident cardiovascular disease: A meta-analysis

(2016) Giovanni Targher et al.   JOURNAL OF HEPATOLOGY

The role of circulating platelet transcripts

(2015) L. Clancy et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Inflammasome activation and function in liver disease

(2015) Gyongyi Szabo et al.   Nature Reviews Gastroenterology & Hepatology

Extravasated platelet aggregation in liver zone 3 may correlate with the progression of sinusoidal obstruction syndrome following living donor liver transplantation: A case report

(2015) SHINICHI NAKANUMA et al.   Experimental and Therapeutic Medicine

A positive feedback loop between RIP3 and JNK controls non-alcoholic steatohepatitis

(2014) J. Gautheron et al.   EMBO Molecular Medicine

Neutrophil extracellular traps form predominantly during the organizing stage of human venous thromboembolism development

(2014) A. S. Savchenko et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

The Liver May Act as a Firewall Mediating Mutualism Between the Host and Its Gut Commensal Microbiota

(2014) M. L. Balmer et al.   Science Translational Medicine

Risk of cardiovascular, cardiac and arrhythmic complications in patients with non-alcoholic fatty liver disease

(2014) Stefano Ballestri   WORLD JOURNAL OF GASTROENTEROLOGY

Relationship Among Circulating Inflammatory Proteins, Platelet Gene Expression, and Cardiovascular Risk

(2013) David D. McManus et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Nucleation of platelets with blood-borne pathogens on Kupffer cells precedes other innate immunity and contributes to bacterial clearance

(2013) Connie H Y Wong et al.   NATURE IMMUNOLOGY

Intravascular Neutrophil Extracellular Traps Capture Bacteria from the Bloodstream during Sepsis

(2012) Braedon McDonald et al.   Cell Host & Microbe

NASH is an Infl ammatory Disorder: Pathogenic, Prognostic and Therapeutic Implications

(2012) Geoffrey C. Farrell et al.   Gut and Liver

Nonalcoholic fatty liver disease and atherosclerosis

(2012) Eugenio Gaudio et al.   Internal and Emergency Medicine

Liver transcriptional profile of atherosclerosis-related genes in human nonalcoholic fatty liver disease

(2011) Silvia Sookoian et al.   ATHEROSCLEROSIS

Platelet transcriptional profile and protein expression in patients with systemic lupus erythematosus: up-regulation of the type I interferon system is strongly associated with vascular disease

(2010) C. Lood et al.   BLOOD

Relation of Platelet and Leukocyte Inflammatory Transcripts to Body Mass Index in the Framingham Heart Study

(2010) Jane E. Freedman et al.   CIRCULATION

Evolution of inflammation in nonalcoholic fatty liver disease: The multiple parallel hits hypothesis

(2010) Herbert Tilg et al.   HEPATOLOGY

The Inflamed Liver and Atherosclerosis: A Link Between Histologic Severity of Nonalcoholic Fatty Liver Disease and Increased Cardiovascular Risk

(2009) Naim Alkhouri et al.   DIGESTIVE DISEASES AND SCIENCES

Increased intestinal permeability and tight junction alterations in nonalcoholic fatty liver disease

(2009) Luca Miele et al.   HEPATOLOGY

NASH Predicts Plasma Inflammatory Biomarkers Independently of Visceral Fat in Men

(2008) Giovanni Targher et al.   Obesity